全文获取类型
收费全文 | 267260篇 |
免费 | 10259篇 |
国内免费 | 6878篇 |
专业分类
耳鼻咽喉 | 1838篇 |
儿科学 | 7613篇 |
妇产科学 | 3848篇 |
基础医学 | 26237篇 |
口腔科学 | 3094篇 |
临床医学 | 24317篇 |
内科学 | 43769篇 |
皮肤病学 | 1737篇 |
神经病学 | 21019篇 |
特种医学 | 12641篇 |
外国民族医学 | 35篇 |
外科学 | 38164篇 |
综合类 | 20179篇 |
现状与发展 | 27篇 |
一般理论 | 7篇 |
预防医学 | 24585篇 |
眼科学 | 5066篇 |
药学 | 19327篇 |
127篇 | |
中国医学 | 7047篇 |
肿瘤学 | 23720篇 |
出版年
2024年 | 256篇 |
2023年 | 1271篇 |
2022年 | 3209篇 |
2021年 | 4385篇 |
2020年 | 3478篇 |
2019年 | 2912篇 |
2018年 | 24788篇 |
2017年 | 20133篇 |
2016年 | 22074篇 |
2015年 | 4968篇 |
2014年 | 5845篇 |
2013年 | 5780篇 |
2012年 | 14042篇 |
2011年 | 28851篇 |
2010年 | 24327篇 |
2009年 | 16184篇 |
2008年 | 25026篇 |
2007年 | 27164篇 |
2006年 | 5829篇 |
2005年 | 7112篇 |
2004年 | 6904篇 |
2003年 | 7697篇 |
2002年 | 5407篇 |
2001年 | 2652篇 |
2000年 | 2496篇 |
1999年 | 1977篇 |
1998年 | 1370篇 |
1997年 | 1357篇 |
1996年 | 986篇 |
1995年 | 912篇 |
1994年 | 830篇 |
1993年 | 494篇 |
1992年 | 508篇 |
1991年 | 512篇 |
1990年 | 481篇 |
1989年 | 380篇 |
1988年 | 337篇 |
1987年 | 276篇 |
1986年 | 211篇 |
1985年 | 174篇 |
1984年 | 93篇 |
1983年 | 69篇 |
1982年 | 51篇 |
1980年 | 63篇 |
1974年 | 27篇 |
1938年 | 60篇 |
1937年 | 25篇 |
1934年 | 30篇 |
1932年 | 56篇 |
1930年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
21.
22.
N. S. Hari Narayana Moorthy Sergio F. Sousa Maria J. Ramos Pedro A. Fernandes 《Medicinal chemistry research》2016,25(7):1340-1357
Farnesyltransferase (FTase) is one of the prenyltransferase family enzymes that catalyse the transfer of 15-membered isoprenoid (farnesyl) moiety to the cysteine of CAAX motif-containing proteins including Rho and Ras family of G proteins. Inhibitors of FTase act as drugs for cancer, malaria, progeria and other diseases. In the present investigation, we have developed two structure-based pharmacophore models from protein–ligand complex (3E33 and 3E37) obtained from the protein data bank. Molecular dynamics (MD) simulations were performed on the complexes, and different conformers of the same complex were generated. These conformers were undergone protein–ligand interaction fingerprint (PLIF) analysis, and the fingerprint bits have been used for structure-based pharmacophore model development. The PLIF results showed that Lys164, Tyr166, TrpB106 and TyrB361 are the major interacting residues in both the complexes. The RMSD and RMSF analyses on the MD-simulated systems showed that the absence of FPP in the complex 3E37 has significant effect in the conformational changes of the ligands. During this conformational change, some interactions between the protein and the ligands are lost, but regained after some simulations (after 2 ns). The structure-based pharmacophore models showed that the hydrophobic and acceptor contours are predominantly present in the models. The pharmacophore models were validated using reference compounds, which significantly identified as HITs with smaller RMSD values. The developed structure-based pharmacophore models are significant, and the methodology used in this study is novel from the existing methods (the original X-ray crystallographic coordination of the ligands is used for the model building). In our study, along with the original coordination of the ligand, different conformers of the same complex (protein–ligand) are used. It concluded that the developed methodology is significant for the virtual screening of novel molecules on different targets. 相似文献
23.
Valerie Iles 《Health care analysis》2016,24(2):105-118
This paper takes a somewhat slant perspective on flourishing and care in the context of suffering, death and dying, arguing that care in this context consists principally of ‘acts of work and courage that enable flourishing’. Starting with the perception that individuals, society and health care professionals have become dulled to death and the process of dying in Western advanced health systems, it suggests that for flourishing to occur, both of these aspects of life need to be faced more directly. The last days of life need to be ‘undulled’. Reflections upon the experiences of the author as carer and daughter in the face of her mother’s experience of death are used as basis for making suggestions about how care systems and professionals might better assist people in dealing with ‘the most grown up thing’ humans ever do, which is to die. 相似文献
24.
25.
26.
27.
28.
目的分析早发型子痫前期应用低分子肝素期待治疗的临床效果。方法回顾分析2017-01—2018-12间在郑州大学第一附属医院产科终止妊娠的95例早发型子痫前期患者的临床资料。按终止妊娠前是否应用低分子肝素分为2组。对照组(47例)给予降压、解痉等治疗;观察组(48例)在对照组基础上加用低分子肝素。结果2组分娩孕周、妊娠延长时间、妊娠并发症发生率、新生儿出生体质量、新生儿窒息及胎儿宫内窘迫发生率、新生儿Apgar评分等,差异均无统计学意义(P>0.05)。结论对早发型子痫前期患者在常规治疗基础上短期应用低分子肝素,不能延长妊娠时间,不改善母婴结局。 相似文献
29.
随着腔镜技术的进一步发展以及微创理念应用于结直肠外科疾病的诊治中,结直肠相关疾病的诊治发生了翻天覆地的变化。由传统的经腹手术到腹腔镜手术、经自然腔道手术,再到经自然腔道取标本手术(NOSES),结直肠疾病的外科诊治在微创领域取得了巨大成果。NOSES技术是目前结直肠外科在微创领域前沿的手术方式之一,它通过经直肠、阴道取标本来避免了腹壁的辅助取标本切口,从而将结直肠外科手术进一步微创化。NOSES技术集传统腹腔镜手术的优势与现代微创外科的理念于一体,它在确保手术效果的基础上集中体现了微创、加速康复外科、功能外科、"无疤"等理念的特点。本文主要就国内外各中心开展NOSES技术在结直肠外科诊治开展中的相关经验、心得和体会进行综述。 相似文献
30.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献